0001437749-19-012693.txt : 20190625 0001437749-19-012693.hdr.sgml : 20190625 20190625163231 ACCESSION NUMBER: 0001437749-19-012693 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20190620 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190625 DATE AS OF CHANGE: 20190625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 19918911 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 8-K 1 tech20190625_8k.htm FORM 8-K tech20190625_8k.htm
false 0000842023 false BIO-TECHNE Corp 0000842023 2019-06-20 2019-06-20

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 20, 2019

 

 

 

BIO-TECHNE CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

Minnesota

0-17272

41-1427402

(State or Other Jurisdiction of

Incorporation)

(Commission File Number)

(I.R.S. Employer Identification

Number)

 

614 McKinley Place NE

Minneapolis, MN 55413

(Address of Principal Executive Offices) (Zip Code)

 

(612) 379-8854

(Registrant’s Telephone Number, Including Area Code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock

TECH

NASDAQ

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

☐

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

Bio-Techne Corporation has expanded the size of the Board of Directors from eight to nine members and elected Dr. Rupert Vessey to the company’s Board of Directors as an independent director.

 

Rupert Vessey, MA, BM BCh, FRCP, DPhil is currently the President of Global Research and Early Development at Celgene, and is anticipated to hold that position at Bristol-Myers Squibb once its acquisition of Celgene is final. Before joining Celgene, Dr. Vessey held various research and development senior management positions at Merck. Dr. Vessey holds an MA in physiological sciences and a BM BCh in clinical medicine from Oxford University where he completed his DPhil at the Institute for Molecular Medicine, Oxford along with additional clinical training at various hospitals in the UK. He is a member of the Royal College of Physicians of London UK.

 

There are no arrangements or understandings between Dr. Vessey and any other persons pursuant to which he was selected as a director.  Additionally, there are no transactions involving the Company and Dr. Vessey that Bio-Techne would be required to report pursuant to Item 404(a) of Regulation S-K. Dr. Vessey will be entitled to receive compensation for his Board service in accordance with the company’s standard compensation arrangements for non-employee directors, which are described under the caption “Director Compensation” in the company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on September 11, 2018, pro-rated for a partial year of service in accordance with company policy.

 

Item 8.01 Other Events

 

A copy of the press release issued by Bio-Techne Corporation on June 25, 2019, announcing Dr. Vessey’s election is attached hereto as Exhibit 99.1.

 

 

Item 9.01 Financial Statements and Exhibits

 

  (d) Exhibits
     

 

99.1

Press Release, dated June 25, 2019, announcing election of Dr. Vessey as a director.

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

BIO-TECHNE CORPORATION

 

 

 

 

 

Date: June 25, 2019

By:

/s/ Brenda S. Furlow

 

 

Brenda S. Furlow

 

 

Senior Vice President, General Counsel and Secretary

 

 

 

 

 

 

EXHIBIT INDEX

 

 

Exhibit No.

Description

 

 

 

 

 

 

 

99.1

Press Release, dated June 25, 2019, announcing election of Dr. Vessey as a director.

 

 EX-99.1 2 ex_148627.htm EXHIBIT 99.1 ex_148627.htm

Exhibit 99.1

 

 

Bio-Techne Appoints Rupert Vessey to Board of Directors

 

 

MINNEAPOLIS, June 25, 2019/PRNewswire/ -- Bio-Techne Corporation today announced the appointment of Dr. Rupert Vessey to the company’s Board of Directors as an independent director. Dr. Vessey’s appointment brings the total number of Bio-Techne Board members to nine.

 

Rupert Vessey, MA, BM BCh, FRCP, DPhil is currently the President of Global Research and Early Development at Celgene, and is anticipated to hold that position at Bristol-Myers Squibb once its acquisition of Celgene is final. Before joining Celgene, Dr. Vessey held various research and development senior management positions at Merck. Prior to his ten years at Merck, Dr. Vessey worked in drug discovery, experimental medicine, and early clinical development at GlaxoSmithKline. Dr. Vessey holds an MA in physiological sciences and a BM BCh in clinical medicine from Oxford University where he completed his DPhil at the Institute for Molecular Medicine, Oxford along with additional clinical training at various hospitals in the UK. He is a member of the Royal College of Physicians of London UK.

 

"We are pleased to welcome Rupert to our board," said Bob Baumgartner, chairman of the board of Bio-Techne. "With his extensive experience in the pharmaceutical and biotech industry, his perspective will be highly valuable as we continue to build on Bio-Techne’s industry-leading capabilities for both research and clinical customers."

 

About Bio-Techne Corporation (NASDAQ: TECH)

 

 

 

Contact: David Clair, Investor Relations 

 

ir@bio-techne.com 

 

646-277-1266

 

 EX-101.SCH 3 tech-20190620.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 tech-20190620_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 tech-20190620_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] DocumentType DocumentPeriodEndDate EntityIncorporationStateCountryCode EntityFileNumber EntityTaxIdentificationNumber EntityAddressAddressLine1 EntityAddressCityOrTown EntityAddressStateOrProvince EntityAddressPostalZipCode CityAreaCode LocalPhoneNumber WrittenCommunications SolicitingMaterial PreCommencementTenderOffer PreCommencementIssuerTenderOffer Security12bTitle TradingSymbol SecurityExchangeName AmendmentFlag EntityCentralIndexKey EntityEmergingGrowthCompany EntityRegistrantName EX-101.PRE 6 tech-20190620_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 tech20190625_8k_htm.xml IDEA: XBRL DOCUMENT 0000842023 2019-06-20 2019-06-20 false 0000842023 false BIO-TECHNE Corp 8-K 2019-06-20 MN 0-17272 41-1427402 614 McKinley Place NE Minneapolis MN 55413 612 379-8854 false false false false Common Stock TECH NASDAQ XML 8 R1.htm IDEA: XBRL DOCUMENT v3.19.2
Document And Entity Information
Jun. 20, 2019
Document Information [Line Items]  
EntityRegistrantName BIO-TECHNE Corp
DocumentType 8-K
DocumentPeriodEndDate Jun. 20, 2019
EntityIncorporationStateCountryCode MN
EntityFileNumber 0-17272
EntityTaxIdentificationNumber 41-1427402
EntityAddressAddressLine1 614 McKinley Place NE
EntityAddressCityOrTown Minneapolis
EntityAddressStateOrProvince MN
EntityAddressPostalZipCode 55413
CityAreaCode 612
LocalPhoneNumber 379-8854
WrittenCommunications false
SolicitingMaterial false
PreCommencementTenderOffer false
PreCommencementIssuerTenderOffer false
Security12bTitle Common Stock
TradingSymbol TECH
SecurityExchangeName NASDAQ
AmendmentFlag false
EntityCentralIndexKey 0000842023
EntityEmergingGrowthCompany false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ^$V4X?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ #X393B?HAPZ" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " /A-E.F4D.N>\ K @ $0 &1O8U!R;W!S+V-O M&ULS9+;2L0P$(9?17+?3@]LP=#MC>*5@N""XEU(9G>#S8%DI-VW-XV[ M740?P,O,_/GF&YA>>BY=P.?@/ ;2&&]F,]K(I=^R(Y'G %$>T8A8IH1-S;T+ M1E!ZA@-X(3_$ :&IJ@X,DE""!"S PJ]$-O1*&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T M$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY M\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4? M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M M&N#C\7@XMLO2BW A(5M>5 TR 6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J M-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2. MFJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$. M$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]07 M2N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL! M_]':-\*K^(+ .7\N?<^E[[GT/:'2MSAD M6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W MF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>( M\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R M4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K> M9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4X MOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5 MYYN MTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+ MA=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'YA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> , M?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H: M,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ M 5!+ P04 " /A-E.:PXZ/J0" "8"P & 'AL+W=OU#89Y/D\:WG=I9O*K^W4II)7T]2=V*E$7]N6JW]; MTP2)4[K]!-[WD+I M"![QNQ9W_3!.W%'V4KZYR;?C.LW=CD0C#L:%X/9Q$R^B:5PDNX^_8]!TTG3$ MQ_%']"_^\/8P>Z[%BVS^U$=S6:?+-#F*$[\VYE7>OXKQ0+,T&4__7=Q$8^%N M)U;C(!OM?Y/#51O9CE'L5EK^/CSKSC_OPYMB/M)H HP$F @ _BR#D-_Y9V[X MIE+RGJCAX_?O[>IMDU?9S849$=L! 0\(-B$R&WL2 M %( /+UXH --+TAZX>GE [T(]H<1)2U0D@(EHL\" 8R8TP(S4F"&Z(M ".6 MM,"<%)@C^BH0P B6TPH+4F&!^2R0(""1/"])B27FAXDF()%,KTB)%>:'J28@ MD5RSG+93CB.$Z:8PD82SB&D9CA#FG,)$DLYHYS) $0 5!P(3*0^,-CC#_@4( M50A,$5&A7&[0S+4(7 Q%1HSS/L M:$!WC,#$5&C;,VSJ MTQC(FJT,YGV-=%6, H3*2" >U]P+XNPAI&82)%#&CO M _9U$98Q"A.I8Q#YU\:^+L(Z1F!B>0':^T#\NX>BK7L_[@ZEQW.ME+8]LSWT2=I#3"QLN?K,LOMDV>)HTX&3=L5A M8F0_]L'9U(QO_@-02P,$% @ #X393AA^#4@L @ F@4 !0 !X;"]S M:&%R9613=')I;F=S+GAM;'U478^;,!!\OOX*E.?F"!SYN"H7B1*NY7)):(E4 MJ54?'-@D5NTUM4TO_/N:I*VNF 0) =[9\Z*C\ M)^I6E( FLA.2$VT^Y=Y5I012J . YLSU!X.1RPG%GE,A_5E!)"K4#[W Z\VF MBLZF>C87><4!M1-BX<2HJ:Z=!,^45.#4U;.IVT#/\*<*;QU_\-;9&CI GEYDV-*?BRCH2A<6X7'63 M/%(&JXIO0;;C@[XW]L=^=]J&')/"N* [FI_V[^8(O+X7^.-@<($F+ H)2OUY M-.?DM8$C+W"6^8(B@]I)&['1%YHAZ4H8>5:EGD5.6'H0>.&<[L;W M_C=SXER_:.,&6)R$R!F#I(2UD:D$AI>,,4Y MM3Y@ 7*]V]GJ6LA$J0KD%7P&>66$UYZ_W5#-+&T-F9GI3(O\1SNVD:0PHK.: M;X4EN9G@2YO%Q_Q < ]=T[\*LWGXJ;T:&C-%8^B1D7UW?T0F*@E+C-7C FIK MO,PU"?R!;_7'.3WF(/?&S0: M%ID>U)/"GE1FT)C3$V5%UAB](WN]*Z32=.7D&?PF1Q3Y/UBML'9^2])[N$^;!%RF-J\%M91*Z0D4FH0ERG&B[,**Q M+ 01C?)&+7AK-)\UK#,6P]-6(.5+.,*OS17WV)"8\[$.QT""BM7TJU[,>%S1 M"?Q'MLA]H+V_B998<3'X8?"KT;/_;3 (SPX:,<[^V&SU/3NW5D[OI6BU@KB6 MWQ9,;BQ89'RM0SKCQ*OG"S>E\@ X2B[@4%1'Y+OC]@PCKK=I;&[5G/Z'FO_V M/K>@P7%Y%.VO_K^\RW^BF"W=>&%S.F7\/#* MJS[9^]33(R_] W[%[^?6T/!!XG-8\1S,Z6Y_"B]-\K!EG3>*G.[V9ZC%H-[. M!?>_1/$#4$L#!!0 ( ^$V4XP_^1R1 $ #P" / >&PO=V]R:V)O M;VLN>&ULC5'+3L,P$/P5RQ] T@HJ435(B/*HA*"BJ'$+X1;;@":L_1%+EAV*OA9SE+'C @"5JI.]"IKL&R5MD%VND',9S M"''N_Q.C:QJL8.FJWH"E(4MB+.+&S6>'GR V_JB?)^.BVA@8MU&\\(##.(51K+^*1=*;7-Y-;#KO7 M^H&Q=_OJ5-*/&N/'W?T 4$L#!!0 ( ^$V4[_P"8(O0 (4" : M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.MDD$*@S 0 +\B>4!7;>FAJ*=> MO+;]0-#5B)J$[);J[YMZ44&A!R\)8LX'LQYT4,CQT>7S%1]_276<]>@C"MA[_)1/TUP.K795]02P,$% @ M#X393@N/V ,A 0 5P0 !, !;0V]N=&5N=%]4>7!E&ULM51-3\,P M#/TK4Z]HS># 6V[ %>8!'\@)&X;-5^RO=']>]QN0V(J8FC;)8GS[/=>$BOS M]VT&FG3!1UH4#7-^4(I, T%3F3)$0:J$0;.$6*NL3:MK4'>SV;TR*3)$GG+/ M42SG3U#IM>?)XVZ_IUX4.F?OC&:7HMI$>T0ZW1.6"'[(H<9ENI&$8O+<"0O) MWJ(0E IU@L)Q81]+W>L&$)V%?UE+5>4,V&3604I*R@C:4@/ P9?4: 3[QNAB MO?>[TL@O.@BQZKSZD5!>SP=O/8P;&)!+*K.T!8Q)#PGPG;83UVX=\@J6$Z[];_:'29RZ!= M_,W(1TKM05\-_\GR"U!+ 0(4 Q0 ( ^$V4X?(\\#P !," + M " 0 !?D !D;V-0&UL4$L! M A0#% @ #X393IE)#KGO *P( !$ ( !F0$ &1O M8U!R;W!S+V-O&UL4$L! A0#% @ #X393IE&PO=V]R:W-H M965T&UL4$L! A0#% @ #X393AA^#4@L @ F@4 !0 M ( !T@L 'AL+W-H87)E9%-T&UL4$L! A0#% M @ #X393KJA.8K7 0 ,@8 T ( !, X 'AL+W-T>6QE M&PO=V]R:V)O;VLN>&UL4$L! A0#% @ #X393O_ )@B] MA0( !H ( !HQ$ 'AL+U]R96QS+W=O XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 1 95 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.tech.com/20190620/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports tech20190625_8k.htm ex_148627.htm tech-20190620.xsd tech-20190620_def.xml tech-20190620_lab.xml tech-20190620_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tech20190625_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "tech-20190620_def.xml" ] }, "inline": { "local": [ "tech20190625_8k.htm" ] }, "labelLink": { "local": [ "tech-20190620_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "tech-20190620_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "tech-20190620.xsd" ], "remote": [ "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 26, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 4, "total": 4 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "tech", "nsuri": "http://www.tech.com/20190620", "report": { "R1": { "firstAnchor": { "ancestors": [ "b", "p", "body", "html" ], "baseRef": "tech20190625_8k.htm", "contextRef": "d20198K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.tech.com/20190620/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "p", "body", "html" ], "baseRef": "tech20190625_8k.htm", "contextRef": "d20198K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "AmendmentFlag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "CityAreaCode" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "DocumentPeriodEndDate" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "DocumentType" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "EntityAddressAddressLine1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "EntityAddressCityOrTown" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "EntityAddressPostalZipCode" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "EntityAddressStateOrProvince" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "EntityCentralIndexKey" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "EntityEmergingGrowthCompany" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "EntityFileNumber" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "EntityIncorporationStateCountryCode" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "EntityRegistrantName" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "EntityTaxIdentificationNumber" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "LocalPhoneNumber" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "PreCommencementIssuerTenderOffer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "PreCommencementTenderOffer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12bTitle" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "Security12bTitle@anonymousType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "SecurityExchangeName" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "SolicitingMaterial" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "TradingSymbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "WrittenCommunications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.tech.com/20190620/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001437749-19-012693-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-19-012693-xbrl.zip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end